Cann Group Ltd (ASX: CAN) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cann Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$27.12 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
437.75 million
Earnings per share
-0.072
Dividend per share
N/A
Year To Date Return
-36.08%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cann Group Ltd (ASX: CAN)
Latest News
Share Gainers
Why BHP, Cann, Nick Scali, & Ramelius shares are pushing higher
Share Market News
Cann (ASX:CAN) share price shoots 16% higher on positive update
Best Shares
5 top ASX cannabis shares in 2020
Share Gainers
ASX pot stocks have been skyrocketing in December
Share Market News
Why the Cann Group (ASX:CAN) share price is up 76% this week
Share Market News
Cann (ASX:CAN) share price flying after AGM
Share Gainers
Cann Group (ASX:CAN) share price rockets on NAB (ASX:NAB) update
Share Gainers
Why Ampol, Cann, Fortescue, & Mesoblast shares are surging higher
Share Market News
ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs
Share Market News
Here's why ASX cannabis shares are falling today
Healthcare Shares
How did ASX cannabis shares perform last quarter?
Share Fallers
The Cann Group share price getting smoked after a strategic shareholder exits
CAN ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cann Group Ltd
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the company; the development and manufacture (via third party arrangements) of finished product formulations; and the pursuit and execution of various supply and offtake agreements with third parties.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 01 Aug 2023 | Douglas (Doug) Rathbone | Issued | 165,515 | $19,861 |
Rights issue.
|
| 01 Aug 2023 | Douglas (Doug) Rathbone | Issued | 82,758 | $9,930 |
Rights issue.
|
| 01 Aug 2023 | Allan McCallum | Issued | 1,459,205 | $175,104 |
Rights issue.
|
| 01 Aug 2023 | Allan McCallum | Issued | 871,649 | $104,597 |
Rights issue.
|
| 01 Aug 2023 | Allan McCallum | Issued | 284,091 | $34,090 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Douglas (Doug) John Rathbone | Non-Executive Director | Mar 2015 |
Mr Rathbone is a public company director. He is the Chairman of the Rathbone Wine Group, Director of Cotton Seed Distributors, Go Resources, AgBiTech. He is also a Chairman of Health Food Holdings and Delta Agribusiness Pty Ltd. Doug is an Honorary Life Governor of the Royal Children's Hospital. He is President of My Room Children's Cancer Charity Limited and founder of Children's Cancer Foundation.
|
| Mr Allan D McCallum | Non-Executive ChairmanNon-Executive Director | Jan 2015 |
Mr McCallum has experience as a public company director in agribusiness and healthcare who has ethics, leadership capabilities and experience in strategy development and implementation, and mergers and acquisitions. Allan is also a member of Rabobank Australia Limited's Advisory Board (wholesale banking).
|
| Dr Julian John Chick | Non-Executive DirectorNon-Executive Deputy Chairman | Oct 2022 |
Dr Chick has over 25 years of experience in the biotechnology and medical technology sectors, as well as in investment banking. He has worked with public and private companies, bringing a number of technologies through from discovery to market, as well as experience in capital raisings, company restructuring, licensing, business development and M&A transactions.
|
| Ms Jennifer (Jenni) Pilcher | Executive Director | Sep 2020 |
Ms Pilcher has experience in the medical and biotechnology sectors. She held senior finance roles at ASX200 company Spotless Group, and in finance teams at Cadbury Schweppes plc, and international pharmaceutical group Medeva plc.,based in London, UK
|
| Mr Robert Gordon Barnes | Non-Executive Director | Sep 2022 |
Mr Barnes is an executive who has delivered leadership and operational outcomes across a variety of healthcare industries, including pharmaceutical, nutraceutical, infant formula, consumer, medical devices, and diagnostics. Having worked globally and in Australia in healthcare organisations, he brings substantial and diverse commercial and scientific understanding to the Company. Robert has held senior executive roles at several pharmaceutical and consumer healthcare entities including Aspen Pharmacare Australia Pty Ltd, Sanofi Australia, and Mayne Group. Mr Barnes has also served on the board of the peak OTC industry body being Consumer Healthcare Products Australia. He has experience in the medicinal cannabis sector, being a former member of the advisory board to Leafcann Group Pty Ltd.
|
| Mr Steven Notaro | Company Secretary | Dec 2023 |
-
|
| Mr Tony Di Pietro | Chief Financial OfficerJoint Company Secretary | Apr 2024 |
-
|
| Tony Di Pietro | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Steven Notaro | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Mr Philip Jacobsen & Mrs Maxine Jacobsen | 11,478,943 | 2.70% |
| Mullacam Pty Ltd | 7,296,023 | 1.71% |
| Flag Capital Pty Ltd | 5,876,453 | 1.38% |
| Mr Leendert Hoeksema | 5,000,000 | 1.17% |
| Citicorp Nominees Pty Limited | 4,601,643 | 1.08% |
| Supernova Fund Pty Ltd | 4,341,363 | 1.02% |
| Mr Christopher John Page | 3,500,000 | 0.82% |
| Mr Ryan Prue | 3,500,000 | 0.82% |
| Ms Shengyan Hu & Mr Xiangjun Zhao | 3,132,224 | 0.74% |
| Invia Custodian Pty Limited | 3,000,000 | 0.70% |
| Hsbc Custody Nominees (Australia) Limited | 2,992,764 | 0.70% |
| Mr Michael Anderson | 2,524,620 | 0.59% |
| T R Samuels Transport Pty Limited | 2,353,029 | 0.55% |
| Hardmail Pty Ltd | 2,150,000 | 0.50% |
| Mrs Robyn Dianne Chandler | 2,100,000 | 0.49% |
| Superhero Securities Limited | 2,085,874 | 0.49% |
| Commonwealth Scientific And Industrial Research Organisation | 1,930,220 | 0.45% |
| Pacific Custodians Pty Limited | 1,626,132 | 0.38% |
| Dr Ayomi Soodin | 1,600,347 | 0.38% |
| Mr Raymond Thomas Hobson & Mrs Rhonda Ellen Hobson | 1,562,895 | 0.37% |
| Mr Allan Donald Mccallum | 1,420,454 | 0.33% |
